ADAM22
- ADAM22
ADAM22 is a gene that encodes a member of the ADAM (a disintegrin and metalloproteinase) family of proteins. These proteins are involved in a variety of biological processes, including cell signaling, adhesion, and migration. ADAM22, in particular, plays a crucial role in the nervous system.
Structure[edit]
The ADAM22 protein is characterized by several distinct domains:
- **Prodomain**: This region is involved in the regulation of the protein's activity.
- **Metalloproteinase domain**: Although ADAM22 is classified as a metalloproteinase, it lacks proteolytic activity due to the absence of a critical zinc-binding motif.
- **Disintegrin domain**: This domain is involved in cell-cell and cell-matrix interactions.
- **Cysteine-rich domain**: This region may play a role in protein-protein interactions.
- **EGF-like domain**: This domain is similar to epidermal growth factor and may be involved in signaling.
- **Transmembrane domain**: This region anchors the protein to the cell membrane.
- **Cytoplasmic tail**: This part of the protein is involved in intracellular signaling pathways.
Function[edit]
ADAM22 is primarily expressed in the brain and is involved in synaptic transmission and plasticity. It interacts with several proteins, including LGI1 (leucine-rich glioma-inactivated 1), which is important for synaptic function. ADAM22 is crucial for the proper functioning of the nervous system and has been implicated in neurological disorders.
Clinical Significance[edit]
Mutations in the ADAM22 gene have been associated with neurological conditions such as epilepsy and intellectual disability. The interaction between ADAM22 and LGI1 is particularly important in the context of epilepsy, as disruptions in this interaction can lead to seizures.
Research[edit]
Ongoing research is focused on understanding the precise mechanisms by which ADAM22 and its interacting partners contribute to neurological function and disease. Studies are also exploring potential therapeutic targets for conditions associated with ADAM22 dysfunction.
Also see[edit]
| ADAM Family | |
|---|---|
|
A Disintegrin and Metalloproteinase |
|
| Members | |
| Functions | |
| Related Topics | |
| See Also | |
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
